ARGX Competitors & Alternatives
Compare argenx NV ADR with similar stocks in the same industry
Biotechnology
ARGX
Main Stock$876.25
Tradestie Score
56
Market Cap
$46.96B
P/E Ratio
38.9
Revenue Growth
0.6%
Analyst Upside
+20.1%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
REGN
Regeneron Pharmaceuticals Inc
|
$663.09
|
$63.59B | 16.2 | 64 | Compare |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$288.06
|
$60.38B | 75.3 | 60 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$303.96
|
$36.81B | 67.6 | 54 | Compare |
|
INSM
Insmed, Inc.
|
$109.14
|
$31.13B | - | 54 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$90.07
|
$24.57B | - | 55 | Compare |
|
GMAB
Genmab A/S ADS
|
$28.80
|
$19.56B | 22.1 | 59 | Compare |
|
INCY
Incyte Genomics Inc
|
$114.23
|
$16.93B | 16.5 | 57 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$56.45
|
$15.70B | 29.7 | 58 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.30
|
$15.22B | - | 53 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$265.22
|
$12.36B | 31.3 | 61 | Compare |
More ARGX Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry